4
Changes in Ownership
MapLight Therapeutics, Inc. Filed Acc 0001789970-26-000010
General Counsel sold 13,917 shares at an average $30.13 ($419,263)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hanson Kristopher · General Counsel
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-11 | Sale : show line 1 in the form 10b5-1 | −284 | $27.61 | $7,841 | 175,964 | D |
| 2026-05-11 | Sale : show line 2 in the form 10b5-1 | −846 | $28.70 | $24,280 | 175,118 | D |
| 2026-05-11 | Sale : show line 3 in the form 10b5-1 | −6,979 | $30.04 | $209,649 | 168,139 | D |
| 2026-05-11 | Sale : show line 4 in the form 10b5-1 | −5,808 | $30.56 | $177,492 | 162,331 | D |
| Open-market sales · 13,917 sh · avg $30.13 · $419,263 | ||||||
Loading xslF345X06/form4-05112026_090506.xml…